Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Real-world treatment patterns and clinical outcomes in patients with essential thrombocythemia treated with cytoreductive therapy: A retrospective analysis of electronic health records data

View Full Paper
Ask AI
Bookmark
Share

Authors

ECEvan C. ChenXYXiaoqin YangMOMavis Obeng‐Kusi

Discussion

Loading...

Member takes

Overview

Retrospective analysis reports thrombosis and symptom control issues in essential thrombocythemia patients on cytoreductive therapy.

Key Points

  • 30.5% of essential thrombocythemia patients experienced complications after initiating cytoreductive therapy, impacting their long-term health.
  • Thrombotic events occurred in 23.2% of patients post-treatment, highlighting critical clinical outcomes that need addressing.
  • A retrospective analysis using ICD10 codes examined outcomes in patients, capturing treatment patterns over an average follow-up of 41 months.
  • Findings emphasize ongoing challenges in managing chronic myeloproliferative neoplasm, illustrating the need for optimized treatment strategies.

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d80ehttps://doi.org/10.1182/blood-2025-2837
View Full Paper
Ask AI
Bookmark
Share